{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:43:49Z","timestamp":1761677029710,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejogrb.2021.07.022","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:56:45Z","timestamp":1626220605000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-2181","authenticated-orcid":false,"given":"Ahmed","family":"Abu-Zaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-8758","authenticated-orcid":false,"given":"Saeed","family":"Baradwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abuzaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed Saeed","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan Saleh","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad Mohammed S.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail Abdulrahman","family":"Al-Badawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.022_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"issue":"9","key":"10.1016\/j.ejogrb.2021.07.022_b0010","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3390\/cancers12092407","article-title":"Genetic Susceptibility to Endometrial Cancer","volume":"12","author":"D\u00f6rk","year":"2020","journal-title":"Risk Factors and Clinical Management. Cancers (Basel)"},{"key":"10.1016\/j.ejogrb.2021.07.022_b0015","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2021.07.022_b0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","article-title":"Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer","volume":"116","author":"Lewin","year":"2010","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0025","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet."},{"issue":"7","key":"10.1016\/j.ejogrb.2021.07.022_b0030","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1586\/era.09.54","article-title":"Systemic therapy for recurrent endometrial cancer: a review of North American trials","volume":"9","author":"Dellinger","year":"2009","journal-title":"Expert Rev Anticancer Ther."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0035","first-page":"51","article-title":"Preoperative Leukocytosis as a Prognostic Marker in Endometrioid-Type Endometrial Cancer: A Single-Center Experience from Saudi Arabia","volume":"1","author":"Salem","year":"2020","journal-title":"Gulf J Oncolog."},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.022_b0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/WHE.14.13","article-title":"Update on prognostic markers for endometrial cancer","volume":"10","author":"Binder","year":"2014","journal-title":"Womens Health (Lond)."},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.022_b0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humpath.2004.02.007","article-title":"Prognostic parameters of endometrial carcinoma","volume":"35","author":"Prat","year":"2004","journal-title":"Hum Pathol."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0050","first-page":"1305","article-title":"Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients","volume":"9","author":"Tejerizo-Garc\u00eda","year":"2013","journal-title":"Onco Targets Ther."},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.022_b0055","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3390\/jcm9061900","article-title":"Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis","volume":"9","author":"Coll-de la Rubia","year":"2020","journal-title":"J Clin Med."},{"issue":"7","key":"10.1016\/j.ejogrb.2021.07.022_b0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00423-020-01962-4","article-title":"Preoperative leukocytosis and the resection severity index are independent risk factors for survival in patients with intrahepatic cholangiocarcinoma","volume":"405","author":"Beetz","year":"2020","journal-title":"Langenbecks Arch Surg."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0065","first-page":"1555","article-title":"The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB\/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial","volume":"18","author":"Holgersson","year":"2017","journal-title":"Asian Pac J Cancer Prev."},{"issue":"11-12","key":"10.1016\/j.ejogrb.2021.07.022_b0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5489\/cuaj.3061","article-title":"The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer","volume":"9","author":"Ozcan","year":"2015","journal-title":"Can Urol Assoc J."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0075","doi-asserted-by":"crossref","unstructured":"Zhang H, Lv H, Weng M, Wang H, Cata JP, Chen W, et al. Preoperative leukocytosis is associated with increased tumor-infiltrating neutrophil extracellular traps and worse outcomes in esophageal cancer. Ann Transl Med. 2020;8:441.","DOI":"10.21037\/atm.2020.03.190"},{"key":"10.1016\/j.ejogrb.2021.07.022_b0080","first-page":"51","article-title":"Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study","volume":"4","author":"Koulis","year":"2017","journal-title":"Clin Transl Radiat Oncol."},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.022_b0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7314\/APJCP.2015.16.3.933","article-title":"Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer","volume":"16","author":"Chen","year":"2015","journal-title":"Asian Pac J Cancer Prev."},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.022_b0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ygyno.2012.03.043","article-title":"The significance of preoperative leukocytosis in endometrial carcinoma","volume":"125","author":"Worley","year":"2012","journal-title":"Gynecol Oncol."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/IGC.0b013e31827da21b","article-title":"Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma","volume":"23","author":"Worley","year":"2013","journal-title":"Int J Gynecol Cancer."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2013.08.032","article-title":"Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas","volume":"131","author":"Nj\u00f8lstad","year":"2013","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.01.043","article-title":"The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC)","volume":"199","author":"Younes","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ijgo.13327","article-title":"Incorporation of pretreatment leukocytosis and thrombocytosis into the FIGO staging system for prognosis in surgically treated endometrial cancer","volume":"151","author":"Yokoi","year":"2020","journal-title":"Int J Gynaecol Obstet."},{"issue":"16","key":"10.1016\/j.ejogrb.2021.07.022_b0115","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/1078-0432.CCR-17-2472","article-title":"The Highly Metastatic Nature of Uterine Cervical\/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations","volume":"24","author":"Sasano","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.07.022_b0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2015.02.006","article-title":"Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study","volume":"137","author":"Takahashi","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.022_b0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13277-010-0079-8","article-title":"Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China","volume":"31","author":"Qiu","year":"2010","journal-title":"Tumour Biol."},{"issue":"7","key":"10.1016\/j.ejogrb.2021.07.022_b0130","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0135","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ejogrb.2021.07.022_b0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0145","first-page":"557","volume":"327","author":"Higgins","year":"2003","journal-title":"Measuring inconsistency in meta-analyses. Bmj."},{"issue":"7109","key":"10.1016\/j.ejogrb.2021.07.022_b0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ejogrb.2021.07.022_b0155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.07.022_b0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00402777","article-title":"Leukocytosis in non hematological malignancies\u2013a possible tumor-associated marker","volume":"111","author":"Shoenfeld","year":"1986","journal-title":"J Cancer Res Clin Oncol."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.thromres.2010.05.012","article-title":"Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy","volume":"126","author":"Connolly","year":"2010","journal-title":"Thromb Res."},{"issue":"7203","key":"10.1016\/j.ejogrb.2021.07.022_b0170","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.ejogrb.2021.07.022_b0175","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1002\/cncr.24480","article-title":"Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study","volume":"115","author":"Granger","year":"2009","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejogrb.2021.07.022_b0180","doi-asserted-by":"crossref","first-page":"e1662708","DOI":"10.1080\/2162402X.2019.1662708","article-title":"The role of myeloid-derived suppressor cells in endometrial cancer displaying systemic inflammatory response: clinical and preclinical investigations","volume":"8","author":"Yokoi","year":"2019","journal-title":"Oncoimmunology."},{"issue":"9484","key":"10.1016\/j.ejogrb.2021.07.022_b0185","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2021.07.022_b0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejogrb.2021.01.038","article-title":"Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis","volume":"258","author":"Abu-Zaid","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0195","first-page":"359","article-title":"Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies","volume":"19","author":"Ye","year":"2020","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.ejogrb.2021.07.022_b0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.022_b0205","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00404-021-06028-4","article-title":"Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer","volume":"303","author":"Raffone","year":"2021","journal-title":"Arch Gynecol Obstet."},{"issue":"1","key":"10.1016\/j.ejogrb.2021.07.022_b0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer."},{"issue":"11","key":"10.1016\/j.ejogrb.2021.07.022_b0215","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers13112623","article-title":"New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO\/ESTRO\/ESP Guidelines","volume":"13","author":"Santoro","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ygyno.2021.02.030","article-title":"Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma","volume":"161","author":"Raffone","year":"2021","journal-title":"Gynecol Oncol."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: Pooled data about prognosis","volume":"155","author":"Raffone","year":"2019","journal-title":"Gynecol Oncol."},{"issue":"3","key":"10.1016\/j.ejogrb.2021.07.022_b0230","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s12253-019-00784-0","article-title":"TCGA Molecular Subgroups in Endometrial Undifferentiated\/Dedifferentiated Carcinoma","volume":"26","author":"Travaglino","year":"2020","journal-title":"Pathol Oncol Res."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0235","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ygyno.2021.02.029","article-title":"Clinico-pathological significance of TCGA classification and SWI\/SNF proteins expression in undifferentiated\/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification","volume":"161","author":"Santoro","year":"2021","journal-title":"Gynecol Oncol."},{"issue":"2","key":"10.1016\/j.ejogrb.2021.07.022_b0240","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/his.13976","article-title":"Clear cell endometrial carcinoma and the TCGA classification","volume":"76","author":"Travaglino","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.ejogrb.2021.07.022_b0245","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00404-020-05542-1","article-title":"Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups","volume":"301","author":"Travaglino","year":"2020","journal-title":"Arch Gynecol Obstet."},{"issue":"5","key":"10.1016\/j.ejogrb.2021.07.022_b0250","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00404-020-05531-4","article-title":"TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma","volume":"301","author":"Travaglino","year":"2020","journal-title":"Arch Gynecol Obstet."}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521003651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521003651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:53:00Z","timestamp":1759557180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521003651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"alternative-id":["S0301211521003651"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.07.022","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}